victrelis
merck sharp dohme ltd - boceprevir - hepatitis c, kronični - antivirusi za sistemsko uporabo - victrelis je indicirano za zdravljenje kroničnega hepatitisa c (chc) genotip 1 okužbe, v kombinaciji z peginterferon alfa in ribavirin pri odraslih bolnikih z nadomestiti bolezen jeter, ki so predhodno nezdravljenih ali ki niso prejšnje zdravljenje.
quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - okužbe, pridobljene v skupnosti - antibacterials za sistemsko uporabo, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
nobilis trt
intervet international -
cefquinor dc
norbrook laboratories (ireland) limited rossmore industrial estate monaghan irska proizvajalec odgovoren za sproščanje serij: norbrook laboratories limited -
klavuxil susp.za injiciranje
genera si -
laksans
genera si -
vetoflok 100mgml
genera si -
cephalexin
genera si -
avipro nd c131
lohmann animal health gmbh -
cefquinor lc
norbrook laboratories (ireland) limited rossmore industrial estate monaghan irska proizvajalec odgovoren za sproščanje serij: norbrook laboratories limited -